230 related articles for article (PubMed ID: 36598340)
1. Classification of GBA1 Variants in Parkinson's Disease: The GBA1-PD Browser.
Parlar SC; Grenn FP; Kim JJ; Baluwendraat C; Gan-Or Z
Mov Disord; 2023 Mar; 38(3):489-495. PubMed ID: 36598340
[TBL] [Abstract][Full Text] [Related]
2. Plasma Glucosylsphingosine in GBA1 Mutation Carriers with and without Parkinson's Disease.
Surface M; Balwani M; Waters C; Haimovich A; Gan-Or Z; Marder KS; Hsieh T; Song L; Padmanabhan S; Hsieh F; Merchant KM; Alcalay RN
Mov Disord; 2022 Feb; 37(2):416-421. PubMed ID: 34741486
[TBL] [Abstract][Full Text] [Related]
3. A Large-Scale Full GBA1 Gene Screening in Parkinson's Disease in the Netherlands.
den Heijer JM; Cullen VC; Quadri M; Schmitz A; Hilt DC; Lansbury P; Berendse HW; van de Berg WDJ; de Bie RMA; Boertien JM; Boon AJW; Contarino MF; van Hilten JJ; Hoff JI; van Mierlo T; Munts AG; van der Plas AA; Ponsen MM; Baas F; Majoor-Krakauer D; Bonifati V; van Laar T; Groeneveld GJ
Mov Disord; 2020 Sep; 35(9):1667-1674. PubMed ID: 32618053
[TBL] [Abstract][Full Text] [Related]
4. Polygenic Parkinson's Disease Genetic Risk Score as Risk Modifier of Parkinsonism in Gaucher Disease.
Blauwendraat C; Tayebi N; Woo EG; Lopez G; Fierro L; Toffoli M; Limbachiya N; Hughes D; Pitz V; Patel D; Vitale D; Koretsky MJ; Hernandez D; Real R; Alcalay RN; Nalls MA; Morris HR; Schapira AHV; Balwani M; Sidransky E
Mov Disord; 2023 May; 38(5):899-903. PubMed ID: 36869417
[TBL] [Abstract][Full Text] [Related]
5. Evolution of prodromal parkinsonian features in a cohort of
Avenali M; Toffoli M; Mullin S; McNeil A; Hughes DA; Mehta A; Blandini F; Schapira AHV
J Neurol Neurosurg Psychiatry; 2019 Oct; 90(10):1091-1097. PubMed ID: 31221723
[TBL] [Abstract][Full Text] [Related]
6. The glucocerobrosidase E326K variant predisposes to Parkinson's disease, but does not cause Gaucher's disease.
Duran R; Mencacci NE; Angeli AV; Shoai M; Deas E; Houlden H; Mehta A; Hughes D; Cox TM; Deegan P; Schapira AH; Lees AJ; Limousin P; Jarman PR; Bhatia KP; Wood NW; Hardy J; Foltynie T
Mov Disord; 2013 Feb; 28(2):232-236. PubMed ID: 23225227
[TBL] [Abstract][Full Text] [Related]
7. Lysosome and Inflammatory Defects in GBA1-Mutant Astrocytes Are Normalized by LRRK2 Inhibition.
Sanyal A; DeAndrade MP; Novis HS; Lin S; Chang J; Lengacher N; Tomlinson JJ; Tansey MG; LaVoie MJ
Mov Disord; 2020 May; 35(5):760-773. PubMed ID: 32034799
[TBL] [Abstract][Full Text] [Related]
8. Imaging and genetics in Parkinson's disease: assessment of the GBA1 mutation.
Ghatti S; Yoon E; Lopez G; Ehrlich D; Horovitz SG
J Neurol; 2022 Oct; 269(10):5347-5355. PubMed ID: 35604467
[TBL] [Abstract][Full Text] [Related]
9. Glucocerebrosidase enzyme activity in GBA mutation Parkinson's disease.
Ortega RA; Torres PA; Swan M; Nichols W; Boschung S; Raymond D; Barrett MJ; Johannes BA; Severt L; Shanker V; Hunt AL; Bressman S; Pastores GM; Saunders-Pullman R
J Clin Neurosci; 2016 Jun; 28():185-6. PubMed ID: 26857292
[TBL] [Abstract][Full Text] [Related]
10. PGRN deficiency exacerbates, whereas a brain penetrant PGRN derivative protects,
Zhao X; Lin Y; Liou B; Fu W; Jian J; Fannie V; Zhang W; Setchell KDR; Grabowski GA; Sun Y; Liu CJ
Proc Natl Acad Sci U S A; 2023 Jan; 120(1):e2210442120. PubMed ID: 36574647
[TBL] [Abstract][Full Text] [Related]
11. The relationship between glucocerebrosidase mutations and Parkinson disease.
Migdalska-Richards A; Schapira AH
J Neurochem; 2016 Oct; 139 Suppl 1(Suppl Suppl 1):77-90. PubMed ID: 26860875
[TBL] [Abstract][Full Text] [Related]
12. Sex distribution and classification of GBA1 variants in an Italian cohort of Parkinson's disease patients analyzed over the last seventeen years.
Panteghini C; Reale C; Colangelo I; Suerz M; Catania A; Garavaglia B; Invernizzi F
Parkinsonism Relat Disord; 2023 Dec; 117():105919. PubMed ID: 37948831
[TBL] [Abstract][Full Text] [Related]
13. Large-scale screening of the Gaucher's disease-related glucocerebrosidase gene in Europeans with Parkinson's disease.
Lesage S; Anheim M; Condroyer C; Pollak P; Durif F; Dupuits C; Viallet F; Lohmann E; Corvol JC; Honoré A; Rivaud S; Vidailhet M; Dürr A; Brice A;
Hum Mol Genet; 2011 Jan; 20(1):202-10. PubMed ID: 20947659
[TBL] [Abstract][Full Text] [Related]
14. Impact of
Stoker TB; Camacho M; Winder-Rhodes S; Liu G; Scherzer CR; Foltynie T; Evans J; Breen DP; Barker RA; Williams-Gray CH
J Neurol Neurosurg Psychiatry; 2020 Jul; 91(7):695-702. PubMed ID: 32303560
[TBL] [Abstract][Full Text] [Related]
15. GBA1 and The Immune System: A Potential Role in Parkinson's Disease?
Al-Azzawi ZAM; Arfaie S; Gan-Or Z
J Parkinsons Dis; 2022; 12(s1):S53-S64. PubMed ID: 36057834
[TBL] [Abstract][Full Text] [Related]
16. Phenotypic effect of GBA1 variants in individuals with and without Parkinson's disease: The RAPSODI study.
Toffoli M; Chohan H; Mullin S; Jesuthasan A; Yalkic S; Koletsi S; Menozzi E; Rahall S; Limbachiya N; Loefflad N; Higgins A; Bestwick J; Lucas-Del-Pozo S; Fierli F; Farbos A; Mezabrovschi R; Lee-Yin C; Schrag A; Moreno-Martinez D; Hughes D; Noyce A; Colclough K; Jeffries AR; Proukakis C; Schapira AHV
Neurobiol Dis; 2023 Nov; 188():106343. PubMed ID: 37926171
[TBL] [Abstract][Full Text] [Related]
17. GBA1 rs3115534 Is Associated with REM Sleep Behavior Disorder in Parkinson's Disease in Nigerians.
Ojo OO; Bandres-Ciga S; Makarious MB; Crea PW; Hernandez DG; Houlden H; Rizig M; Singleton AB; Noyce AJ; Nalls MA; Blauwendraat C; Okubadejo NU;
Mov Disord; 2024 Apr; 39(4):728-733. PubMed ID: 38390630
[TBL] [Abstract][Full Text] [Related]
18. GBA1 mutations: Prospects for exosomal biomarkers in α-synuclein pathologies.
Johnson PH; Weinreb NJ; Cloyd JC; Tuite PJ; Kartha RV
Mol Genet Metab; 2020 Feb; 129(2):35-46. PubMed ID: 31761523
[TBL] [Abstract][Full Text] [Related]
19. Cholinergic innervation topography in GBA-associated de novo Parkinson's disease patients.
Slingerland S; van der Zee S; Carli G; Slomp AC; Boertien JM; d'Angremont E; Bohnen NI; Albin RL; van Laar T
Brain; 2024 Mar; 147(3):900-910. PubMed ID: 37748026
[TBL] [Abstract][Full Text] [Related]
20. Cytokines and Gaucher Biomarkers in Glucocerebrosidase Carriers with and Without Parkinson Disease.
Galper J; Balwani M; Fahn S; Waters C; Krohn L; Gan-Or Z; Dzamko N; Alcalay RN
Mov Disord; 2021 Jun; 36(6):1451-1455. PubMed ID: 33570220
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
